Spontaneous reduction in macroprolactinoma volume during pregnancy and after birth: A case report
Department of Endocrinology, Diabetology, Metabolic Diseases and Nutrition, Mohammed VI University Hospital of Marrakesh, Morocco.
Case Study
World Journal of Advanced Research and Reviews, 2023, 17(01), 1202–1205
Article DOI: 10.30574/wjarr.2023.17.1.0174
Publication history:
Received on 19 December 2022; revised on 26 January 2023; accepted on 28 January 2023
Abstract:
Prolactinoma, the most common secretory pituitary tumor, is found in 100 patients per million. It is responsible for impaired reproductive function in both sexes. Its treatment in the context of fertility restoration gives very satisfactory results. The natural history of these tumors in the gestational period is variable depending on their size with a clinically significative risk ranging from 5 to 30%. Their management is complex, requiring evaluation of the effects of pregnancy on tumor growth and the effects of therapy on embryonic and fetal development. We report the case of 23years patient with a macroprolactinoma and the successful outcome of this tumor during the pregnancy.
Keywords:
Macroprolactinoma; Pregnancy; Dopamine agonists; Magnetic resonance imaging; GOLDMANN visual field
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0